Cardiovascular Disease Mortality Progress Slowing Down in U.S.

This article originally appeared here.
Share this content:
Cardiovascular Disease Mortality Progress Slowing Down in U.S.
Cardiovascular Disease Mortality Progress Slowing Down in U.S.

WEDNESDAY, June 29, 2016 (HealthDay News) -- The rate of decline in cardiovascular disease mortality has decelerated, according to research published online June 29 in JAMA Cardiology.

In an effort to determine whether changes in national trends had occurred in recent years in cardiovascular disease mortality rates, Stephen Sidney, M.D., M.P.H., director of research clinics at Kaiser Permanente Northern California in Oakland, and colleagues analyzed data from the U.S. Centers for Disease Control and Prevention.

The researchers found that the annual mortality rate dropped 3.69 percent for heart disease and 4.53 percent for stroke from 2000 to 2011. However, those rates dropped less than 1 percent from 2011 to 2014. Through this time, the annual rate of decline in cancer deaths remained stable, at 1.49 percent. The slowing in the decline of the mortality rate from heart disease and stroke occurred in men and women, and in most racial and ethnic groups, the investigators noted.

Before 2011, it was anticipated that the mortality rate from heart disease would become lower than the cancer death rate, and heart disease would no longer be the leading cause of death in the United States for the first time in nearly 100 years, Sidney told HealthDay. But, "because of the deceleration in the decline of heart mortality, it still remains the leading cause of death," he said.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »